FIELD: medicine.
SUBSTANCE: erythropoetin is used for manufacture of medication for stimulation of accelerated structural tissue regeneration after hepatic resection in patient with benign and malignant tumours.
EFFECT: invention allows forming vascular net around resectional surface, restoring normal architecture of acinus, interacinal connective tissue, central veins and hepatic triads and achieving original sizes of liver.
3 cl, 3 ex
